ArticleIranian journal of public health2020
Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients.
Article in Iranian journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of progesterone receptor status with breast cancer prognosis: a meta-analysis.World journal of surgical oncology · 2025Pooled it
- Comprehensive survival analysis of breast cancer patients: a bayesian network approach.BMC medical informatics and decision making · 2025Article
- Survival Rate of Breast Cancer and Related Factors in Iran: A 27-Year Follow-Up.Iranian journal of public health · 2025Article
- Economic burden of breast cancer: a case of Southern Iran.Cost effectiveness and resource allocation : C/E · 2023Article
- Article
- Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models.Frontiers in oncology · 2023Article
- Neoadjuvant VS adjuvant chemotherapy in patients with locally advanced breast cancer; a retrospective cohort study.Annals of medicine and surgery (2012) · 2022Article
- Long-Term Oncologic Outcome of Breast Cancer in Southern Iran: A Retrospective Cohort Study.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer.Iranian journal of public health · 2022Article
- Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study.JCO global oncology · 2021Article
- Synthesis, radiolabelling, and biological assessment of folic acid-conjugated G-3IET nanobiotechnology · 2020Article
- The Effect of a Program Based on the Common-Sense Model on Illness Perception and Health-Promoting Behaviors in Women with Breast Cancer: A Randomized Clinical Trial Study.Iranian journal of nursing and midwifery researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurvival time is one of the indicators used for evaluation of the quality of care in different types of malignancies, including breast cancer. The present study aimed to estimate the survival rate of breast cancer and its related factors among Iranian patients.
methodsOverall, 3148 cases of breast cancer who referred to the Cancer Research Center in Shahid Beheshti University of Medical Sciences, Tehran, Iran during 1994-2017 participated in this longitudinal study. Survival estimates were calculated using the Kaplan-Meier method and the Bayesian generalized Birnbaum-Saunders model with cure rate from geometric distribution. Clinical, pathological, and biological variables as potential prognostic factors were entered in univariate and multivariate analyses.In order to identify the significant prognostic factors, 95% highest posterior density (HPD) intervals were used.
resultsThe overall 1, 5, 10, 15, 20 and 25-year survival rate were 95%, 75%, 60%, 47%, 46% and 46%, respectively. A significant relation was observed between survival time and the variables such as age, size of tumor, number of lymph nodes, stage, histological grade, estrogen receptor, progesterone receptor, and lymphovascular invasion.
conclusionThe findings of this study might help the health managers to plan long-term programs considering regional determinants, public education, and screening for early detection of breast cancer cases which can eventually influence the overall survival rate of these patients.
Indexed as
Identifiers
32461942PMC7231718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.